Thus, the targets regulating the expression of TGF-β, TGF-βR1 and p53 or the phosphorylation level of SMAD3 in the TGF-β signaling pathway have yet to be explained, and will increase our understanding and provide novel tools for diagnosis and treatment of metastatic PCa. Here, TGFBR1 is linked to posterior cortical atrophy.